In this Issue  by unknown
Kidney International (2012) 81             805
http://www.kidney-international.org
© 2012 International Society of Nephrology
in  this  issue
Kidney International (2012) 81, 805. doi:10.1038/ki.2012.79
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Generation of  
renal lymphatics
Much research has focused on the roles 
of transforming growth factor-b (TGF-
b) and vascular endothelial growth 
factor (VEGF) in modulating kidney 
fibrosis and endothelial dysfunction, 
respectively. Far less is known about 
the role of kidney lymphatics in the 
progression of kidney diseases. In this 
issue, Suzuki et al. report that in the rat 
unilateral ureteral obstruction model 
of renal fibrosis, production of TGF-b 
by renal parenchymal cells increased 
VEGF-C expression, thereby promot-
ing lymphangiogenesis. They further 
demonstrated that TGF-b inhibition 
induced a reduction in renal fibrosis that 
was accompanied by a parallel decrease 
in lymphangiogenesis. This study associ-
ates TGF-b with VEGF-C, and thereby 
renal lymphangiogenesis and fibrosis. 
Unfortunately, the causal role of neo-
lymphangiogenesis in the progression 
of chronic kidney disease remains to be 
elucidated. See page 865.
Epithelial 
dediffer entiation  
and fibrosis
Tubulointerstitial inflammation is a criti-
cal contributor to the progression of most 
types of chronic kidney disease. Li et al. 
report that the transcription factor inhibi-
tor of differentiation-1 (Id1) is selectively 
upregulated in proximal tubular and col-
lecting duct epithelial cells in mice sub-
jected to unilateral ureteral obstruction. 
Importantly, they also found that Id1 
expression was highest in tubules with 
adjacent peritubular inflammation in 
biopsies from patients with chronic kidney 
diseases. A causative role for Id1 in poten-
tiating tubulointerstitial inflammation was 
further supported by data demonstrating 
that Id1 promotes nuclear factor-kB acti-
vation in vitro and that Id1 knockout mice 
have reduced tubulointerstitial injury after 
unilateral ureteral obstruction. These find-
ings point to Id1 as a potential switch con-
necting epithelial injury and interstitial 
inflammation in the process of interstitial 
fibrosis. See page 880.
Erythropoietin  
and allograft 
transplant injury
Anemia has been related to chronic trans-
plant nephropathy and outcome. Cassis et 
al. examined the effect of erythropoietin 
(EPO) administration on the correction 
of anemia and transplant function in a 
rat model of kidney transplantation. EPO 
treatment corrected post-transplantation 
anemia and ameliorated the progressive 
graft dysfunction, whereas correction of 
anemia by blood transfusions did not elim-
inate the allograft injury. EPO influenced 
selective intragraft cytokines and markers 
of apoptosis in a manner consistent with 
some non-erythropoietic, cytoprotective 
actions of EPO. These data are of interest 
in the ongoing discussion of renoprotective 
actions of EPO. However, a recent clinical 
study in patients with deceased-donor 
kidney transplantation did not show such 
a graft protection with high-dose EPO 
administration.1 The reasons for this dis-
crepancy remain to be determined, but for 
the time being, there appear to be insuf-
ficient grounds for EPO administration 
beyond anemia correction in human kid-
ney transplantation. See page 903.
1Kidney Int 2012; 81: 314–320.
